QA: Skye Bioscience Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2025_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516551, Skye Bioscience Inc

  xvar xval
0 AssetsCurrent 70,827,247
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,432,752
3 remainder_Assets 503,774
4 LiabilitiesCurrent 4,338,887
5 LiabilitiesNoncurrent 273,162
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 66,976,152
9 ResearchAndDevelopmentExpense 17,986,131
10 remainder_Expenses 20,885,080
11 remainder_Revenues 0
12 remainder_NetIncome 545,427
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 72,763,773
1 Liabilities 4,612,049
2 Expenses 105,847,363
3 Revenues 0
4 StockholdersEquity 68,151,724
5 NetIncome -105,301,936
6 ComprehensiveNetIncome -105,301,936
7 BaseVar 91,884,306
8 EconomicCapitalRatiobeforeLimitedLiability 1.12
9 EconomicCapitalRatio 2.39

Edgar->Model Mapping

Feature Distribution

Change over Time